Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (71)	4/9/1999 4:16:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 555

well..... I don't know who the "someone" is for the other 110, but the last 20 were mine. I decided that, with phase II prostate data to be presented at ASCO, the AACR bet might be worth it. There's always the chance that Blitzer's european partner will clarify. Kept my shares too, as the downside seems limited by ASCO and Sjogren's. I usually don't like these situations where a bunch of quiet people are betting on out of the money calls. I'll bet they're all Cathcart and friends. :-) Something stinks Please note that (1) I bought mine at 15:45, well after I made the post to the SUGN thread and at the day's high, and (2) the 20 for the 15:45 trade is the only option position that I hold (or have ever held, I believe) on MOGN. It will be interesting to compare today's and tomorrow's open interest.